• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

Sanofi S.A. (Euronext: SAN, Nasdaq: SNY)

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

 

	Start	2011-05-06 renamed
	Group	Sanofi (Group) [since May 2011]
	Predecessor	Sanofi-Aventis S.A. (EURONEXT: SAN, NYSE: SNY)
	Industry	pharmaceutical
	Person	Hudson, Paul (Sanofi 201909– CEO before Novartis Head Pharma before AstraZeneca + Schering-Plough)
	Person 2	Contamine, Jérôme (Sanofi 2009–201809 CFO RETIRED 9/18)
	Region	Paris
	Country	France
	Street	174 avenue de France
	City	75635 Paris Cedex 13
	Tel	+33-1-5377-4000
		Address record changed: 2020-12-02
Basic data	Employees	I: 50,001 to 100,0 (2021-12-31)
	Currency	EUR
	Annual sales	37,761,000,000 (sales, net, consolidated (2021) 2021-12-31)
	Profit	6,279,000,000 (2021-12-31)
	Cash	10,098,000,000 (2021-12-31)
		* Document for �About Section�:
		Record changed: 2022-04-04

Advertisement

More documents for Sanofi (Group) [since May 2011]

• [1] Sanofi S.A.. (3/29/22). "Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets". Paris....
• [2] Sanofi S.A.. (3/16/22). "Press Release: Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates". Paris....
• [3] Sanofi S.A.. (3/15/22). "Press Release: Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance an Innovative Treatment for Multiple Myeloma". Paris....
• [4] Sanofi S.A.. (2/8/22). "Press Release: Sanofi Completes Acquisition of Amunix". Paris....
• [5] Exscientia plc. (1/7/22). "Press Release: Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines". Paris, Oxford & Boston, MA....
• [6] Sanofi S.A.. (12/21/21). "Press Release: Sanofi to Acquire Amunix Immuno-oncology Pipeline with Next Generation Conditionally Activated Biologics". Paris....
• [7] Corteria Pharmaceuticals S.A.S.. (12/9/21). "Press Release: Corteria Pharmaceuticals Announces Closing of €12M Seed Financing to Advance Portfolio Assets". Paris....
• [8] Sanofi S.A.. (12/1/21). "Press Release: Sanofi to Acquire Origimm Biotechnology in First Move to Treat Acne with Vaccine-based Immunotherapy". Paris & Vienna....
• [9] Novalix S.A.S.. (11/30/21). "Press Release: Novalix Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries". Strasbourg....
• [10] Sanofi S.A.. (11/18/21). "Press Release: Sanofi Invests $180 Million Equity in Owkin’s Artificial Intelligence and Federated Learning to Advance Oncology Pipeline". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.